13F

LXRX LEXICON PHARMACEUTICALS INC

2026Q1 · CUSIP 528872302 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
137
Δ holders QoQ
+12
Breadth percentile
Top 25%
Whale holders
63
Δ whales
+8
Inst. holding value
$505M
New positions
32
Closed positions
20
Price momentum (1Q)
+62.1%
Put / Call
3/3

Breadth history (34 quarters)

2018Q1: Δ-7 · h=124 2018Q2: Δ-4 · h=120 2018Q3: Δ-1 · h=119 2018Q4: Δ+3 · h=122 2019Q1: Δ-1 · h=121 2019Q2: Δ-12 · h=109 2019Q3: Δ-5 · h=104 2019Q4: Δ+12 · h=116 2020Q1: Δ-3 · h=113 2020Q2: Δ-4 · h=109 2020Q3: Δ-16 · h=93 2020Q4: Δ+15 · h=108 2021Q1: Δ+1 · h=109 2021Q2: Δ-3 · h=106 2021Q3: Δ-9 · h=97 2021Q4: Δ+14 · h=111 2022Q1: Δ-10 · h=101 2022Q2: Δ-13 · h=88 2022Q3: Δ+11 · h=99 2022Q4: Δ+7 · h=106 2023Q1: Δ-1 · h=105 2023Q2: Δ+20 · h=125 2023Q3: Δ-12 · h=113 2023Q4: Δ-5 · h=108 2024Q1: Δ+11 · h=119 2024Q2: Δ+9 · h=128 2024Q3: Δ+10 · h=138 2024Q4: Δ-11 · h=127 2025Q1: Δ+0 · h=127 2025Q2: Δ-2 · h=125 2025Q3: Δ+0 · h=125 2025Q4: Δ+0 · h=125 2026Q1: Δ+12 · h=137 2018Q1: holders=124 2018Q2: holders=120 2018Q3: holders=119 2018Q4: holders=122 2019Q1: holders=121 2019Q2: holders=109 2019Q3: holders=104 2019Q4: holders=116 2020Q1: holders=113 2020Q2: holders=109 2020Q3: holders=93 2020Q4: holders=108 2021Q1: holders=109 2021Q2: holders=106 2021Q3: holders=97 2021Q4: holders=111 2022Q1: holders=101 2022Q2: holders=88 2022Q3: holders=99 2022Q4: holders=106 2023Q1: holders=105 2023Q2: holders=125 2023Q3: holders=113 2023Q4: holders=108 2024Q1: holders=119 2024Q2: holders=128 2024Q3: holders=138 2024Q4: holders=127 2025Q1: holders=127 2025Q2: holders=125 2025Q3: holders=125 2025Q4: holders=125 2026Q1: holders=137 -20 -10 +0 +10 +20 79112145 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q2 Top 10% -30.4% +122.4%
2022Q3 Top 12% +6.1% +31.4%

Options Sentiment

Put holders
3
QoQ: +1
Call holders
3
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.07
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
+123.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0M 2022-09-30: $0M 2023-03-31: $0M 2023-06-30: $0M 2023-09-30: $0M 2023-12-31: $1M 2024-03-31: $1M 2024-06-30: $2M 2024-09-30: $2M 2024-12-31: $27M 2025-03-31: $1M 2025-06-30: $29M 2025-09-30: $14M 2025-12-31: $5M 2026-03-31: $21M 2022-06-30: EPS -0.16 2022-09-30: EPS -0.13 2022-12-31: EPS -0.17 2023-03-31: EPS -0.17 2023-06-30: EPS -0.22 2023-09-30: EPS -0.21 2023-12-31: EPS -0.20 2024-03-31: EPS -0.20 2024-06-30: EPS -0.17 2024-09-30: EPS -0.18 2024-12-31: EPS -0.08 2025-03-31: EPS -0.07 2025-06-30: EPS 0.01 2025-09-30: EPS -0.04 2025-12-31: EPS -0.04 2026-03-31: EPS 0.00 0M 14M 29M $M -0.24 -0.12 0.01 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)